Curonix

What Curonix does

Curonix is a privately-held medical device company that develops and markets implantable neurostimulation systems for chronic pain management. Headquartered in Pompano Beach, Florida, the company sells the Freedom platform, which comprises the Freedom Peripheral Nerve Stimulator (PNS) System and the Freedom Spinal Cord Stimulator (SCS) System. Both systems are built on Curonix's proprietary High Frequency-Electromagnetic Coupling (HF-EMC) technology, which delivers power through the skin from an external transmitter to a battery-free implanted receiver, eliminating the need for implanted batteries and the associated pocket pain, replacement surgeries, and IPG-related complications. The platform is complemented by NervPulse Therapy — a nerve-specific programming module with therapy programs for 33 peripheral nerves — and a family of purpose-built wearables (Extremity, Torso, Upper Torso, and Head/Neck) designed for different anatomical indications.

Curonix serves healthcare providers across multiple specialties, including pain management physicians, interventional pain specialists, orthopedic surgeons, spine surgeons, and interventional radiologists, who implant the Freedom systems in patients suffering from chronic intractable pain of peripheral nerve and spinal origin. The company reports more than 20,000 patients treated and 30,000 cumulative Freedom PNS procedures, supported by a clinical evidence base of 44 publications covering 495+ study patients. Curonix also operates Curonix Connect, a reimbursement support platform providing insurance verification, prior authorization, and appeals assistance that is integral to provider adoption given the complexity of neurostimulation reimbursement. As of April 2026, expanded reimbursement coverage provides access to an additional 27 million covered lives.

Curonix operates a direct enterprise field sales model targeting healthcare providers in the United States, with international websites supporting English and German-speaking markets. Devices are sold to providers who then bill payers, including Medicare and commercial plans, on a quote-based pricing model that is not publicly disclosed. The go-to-market is reinforced by national and international bioskills training courses featuring didactic and cadaveric instruction, conference presence at ASPN and AOFAS, comprehensive website content for both providers and patients, and a physician locator tool that drives patient referrals to provider customers. Curonix holds an extensive U.S. patent portfolio covering its electrode arrays, external transmitters, antennas, and wearable components, and operates under AdvaMed Code of Ethics compliance.

Name

Curonix

Legal name

Curonix LLC

Website

https://curonix.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Curonix is a privately-held medical device company that develops and markets battery-free implantable neurostimulation systems (Freedom PNS and SCS) using its proprietary HF-EMC technology, serving pain management physicians, orthopedic surgeons, and spine surgeons treating chronic intractable pain.

Ownership category

akta.pro rank

Product category

Implantable Neurostimulation Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

Keywords

• Peripheral nerve stimulation
• Spinal cord stimulation
• Implantable neurostimulators
• Chronic pain devices
• Electromagnetic coupling implants

Headquarters

HQ city

Pompano Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

1. Medical Device Sales: Curonix generates revenue through the sale of its Freedom PNS and Freedom SCS implantable neurostimulation systems. The systems are two-component permanent implant systems that include electrode arrays, implanted receivers, external transmitter assemblies, and wearable accessories. Revenue is generated through healthcare providers who implant the devices in patients suffering from chronic pain conditions.
2. Professional Services - Reimbursement Support: Curonix offers reimbursement support services through Curonix Connect, including insurance verification, prior authorization, and appeals support. While primarily a customer service function to facilitate device access, these services may generate professional services revenue through healthcare economics consulting.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Curonix manufactures and distributes FDA-cleared implantable neurostimulation systems for chronic pain management. Its core Freedom System platform consists of two-component permanent implant devices — the Freedom Peripheral Nerve Stimulator (PNS) System and Freedom Spinal Cord Stimulator (SCS) System — that use proprietary High Frequency-Electromagnetic Coupling (HF-EMC) technology to power the implanted receiver through the skin without an implanted battery. The company sells directly to healthcare providers and supports them with reimbursement services through Curonix Connect.

Product overview

Curonix offers the Freedom® System platform, a family of neurostimulation products for chronic pain management. The platform consists of two core products: the Freedom Peripheral Nerve Stimulator (PNS) System for peripheral nerve pain and the Freedom Spinal Cord Stimulator (SCS) System for trunk and lower limb pain. Both systems share a common technology architecture using High Frequency-Electromagnetic Coupling (HF-EMC) that eliminates the need for implanted batteries by powering the device through the skin. The platform includes the NervPulse™ Therapy module for nerve-specific programming with 33 therapy programs, multiple electrode array configurations (4-contact and 8-contact), external transmitter assemblies, and purpose-built wearable accessories (Extremity, Torso, Upper Torso, and Head/Neck wearables). The system also includes the Curonix Connect reimbursement support platform.

Differentiator

Problem solved

Functional benefit

Brands

• Freedom: Freedom PNS (Peripheral Nerve Stimulator) System and Freedom SCS (Spinal Cord Stimulator) System - two-component permanent implant systems using HF-EMC technology for chronic pain relief.
• NervPulse

Products and services

• Freedom Peripheral Nerve Stimulator (PNS) System A two-component permanent implant system for chronic pain relief that includes an electrode array, separate implanted receiver, external transmitter assembly, and wearable accessory. Uses High Frequency-Electromagnetic Coupling (HF-EMC) technology to power the implanted neurostimulator through the skin without an implanted battery. Indicated for chronic intractable pain of peripheral nerve origin including post-surgical pain, mononeuropathies, knee, foot, ankle, shoulder, head, neck, and craniofacial pain.
• Freedom Spinal Cord Stimulator (SCS) System

Quantifiable outcome

• 47% medication reduction at 24 months post-implant
• +6 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Saluda Medical: Saluda Medical is developing closed-loop SCS technology with significant clinical evidence, positioning it as an emerging competitor in the spinal cord stimulation space where Curonix's Freedom SCS also competes.
• Mainstay Medical: Mainstay Medical offers the ReActiv8 restorative neurostimulation system for chronic low back pain, targeting a partially overlapping patient population with Curonix's SCS for intractable back and leg pain.

Direct peers

• Nevro Corp: Nevro markets the Senza spinal cord stimulation system, including 10 kHz HF therapy, and is a direct competitor to Curonix's Freedom SCS in the chronic pain neurostimulation market with the same target prescribers and payors.
• SPR Therapeutics: SPR Therapeutics markets the SPRINT PNS System for peripheral nerve stimulation, directly competing with Curonix's Freedom PNS for the same pain management and orthopedic indications.
• Axonics: Axonics markets the r-SNM sacral neuromodulation system and is developing expansion indications in chronic pain, making it a relevant neuromodulation peer using similar battery-life and miniaturization design philosophies.
• Nalu Medical: Nalu Medical offers a battery-free, externally-powered implantable neurostimulator for chronic pain, directly competing with Curonix's HF-EMC battery-free architecture in the PNS market.

Broad incumbents

• Medtronic: Medtronic is the largest neuromodulation incumbent offering the Intellis and Vanta spinal cord stimulators and a broad DBS portfolio, competing with Curonix across multiple neurostimulation segments with deep payor relationships.
• Boston Scientific: Boston Scientific offers the WaveWriter and Precision Spectra SCS systems and a deep neuromodulation portfolio, competing with Curonix across chronic pain with a larger sales force and broader payer contracts.
• Abbott: Abbott (formerly St. Jude Medical) markets the Proclaim SCS and DRG systems for chronic pain, competing with Curonix's Freedom SCS using established sales coverage in pain management and neurosurgery.
• Biotronik: Biotronik markets the Prospera and Acticor SCS systems for chronic pain, competing with Curonix's Freedom SCS through European and US sales channels with established physician relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCx1a_SampleUrl
• Xx.com/CuronixCompany
• Facebookfacebook.com/curonix
• LinkedInlinkedin.com/company/curonix

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curonix